UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 97

Sortiert nach

Socioeconomic inequality in prostate cancer diagnostics, primary treatment, rehabilitation, and mortality in Sweden

International journal of cancer, 2024-08, Vol.155 (4), p.637-645

2024

Volltextzugriff (PDF)

Risk of severe late toxicity after radiotherapy following radical prostatectomy – a nationwide study

BJU international, 2022-12, Vol.130 (6), p.799-808

2022

Volltextzugriff (PDF)

Re‐treatment with radium‐223: 2‐year follow‐up from an international, open‐label, phase 1/2 study in patients with castration‐resistant prostate cancer and bone metastases

The Prostate, 2019-10, Vol.79 (14), p.1683-1691

2019

Volltextzugriff (PDF)

Hyaluronic acid spacer in prostate cancer radiotherapy: dosimetric effects, spacer stability and long-term toxicity and PRO in a phase II study

Radiation oncology (London, England), 2023-01, Vol.18 (1), p.1-1, Article 1

2023

Volltextzugriff (PDF)

Accuracy of gross tumour volume delineation with [68Ga]-PSMA-PET compared to histopathology for high-risk prostate cancer

Acta oncologica, 2024-06, Vol.63 (1), p.503-510

2024

Volltextzugriff (PDF)

Deep learning‐based classification and structure name standardization for organ at risk and target delineations in prostate cancer radiotherapy

Journal of applied clinical medical physics, 2021-12, Vol.22 (12), p.51-63

2021

Volltextzugriff (PDF)

The Swedish national guidelines on prostate cancer, part 1: early detection, diagnostics, staging, patient support and primary management of non-metastatic disease

Scandinavian journal of urology, 2022, Vol.56 (4), p.265-273

2022

Volltextzugriff (PDF)

Epithelial and Stromal Characteristics of Primary Tumors Predict the Bone Metastatic Subtype of Prostate Cancer and Patient Survival after Androgen-Deprivation Therapy

Cancers, 2022-10, Vol.14 (21), p.5195

2022

Volltextzugriff (PDF)

Registration of histopathology to magnetic resonance imaging of prostate cancer

Physics and imaging in radiation oncology, 2021-04, Vol.18, p.19-25

2021

Volltextzugriff (PDF)

Clinical and biological relevance of the transcriptomic‐based prostate cancer metastasis subtypes MetA‐C

Molecular oncology, 2022-02, Vol.16 (4), p.846-859

2022

Volltextzugriff (PDF)

Characteristics of Patients in SPCG-15—A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate Cancer

European urology open science (Online), 2022-07, Vol.41, p.63-73

2022

Volltextzugriff (PDF)

The grade of individual prostate cancer lesions predicted by magnetic resonance imaging and positron emission tomography

Communications medicine, 2023-11, Vol.3 (1), p.164-164, Article 164

2023

Volltextzugriff (PDF)

Patient-induced susceptibility effects simulation in magnetic resonance imaging

Physics and imaging in radiation oncology, 2017-01, Vol.1, p.41-45

2017

Volltextzugriff (PDF)

Platelets harbor prostate cancer biomarkers and the ability to predict therapeutic response to abiraterone in castration resistant patients

The Prostate, 2018-01, Vol.78 (1), p.48-53

2018

Volltextzugriff (PDF)

Estrogen Receptor β Polymorphism Is Associated with Prostate Cancer Risk

Clinical cancer research, 2006-03, Vol.12 (6), p.1936-1941

2006

Volltextzugriff (PDF)

The Swedish national guidelines on prostate cancer, part 2: recurrent, metastatic and castration resistant disease

Scandinavian journal of urology, 2022, Vol.56 (4), p.278-284

2022

Volltextzugriff (PDF)

Quantifying the Effect of 3T Magnetic Resonance Imaging Residual System Distortions and Patient-Induced Susceptibility Distortions on Radiation Therapy Treatment Planning for Prostate Cancer

International journal of radiation oncology, biology, physics, 2018-02, Vol.100 (2), p.317-324

2018

Volltextzugriff (PDF)

U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden

Acta oncologica, 2018-02, Vol.57 (2), p.187-194

2018

Volltextzugriff (PDF)

11C-Acetate-PET/CT Compared to 99mTc-HDP Bone Scintigraphy in Primary Staging of High-risk Prostate Cancer

Anticancer research, 2016-12, Vol.36 (12), p.6475-6480

2016

Volltextzugriff (PDF)

High Monocyte Count and Expression of S100A9 and S100A12 in Peripheral Blood Mononuclear Cells Are Associated with Poor Outcome in Patients with Metastatic Prostate Cancer

Cancers, 2021-05, Vol.13 (10), p.2424

2021

Volltextzugriff (PDF)

Histopathology-validated gross tumor volume delineations of intraprostatic lesions using PSMA-positron emission tomography/multiparametric magnetic resonance imaging

Physics and imaging in radiation oncology, 2024-07, Vol.31, p.100633, Article 100633

2024

Volltextzugriff (PDF)

Impact of neoadjuvant androgen deprivation therapy on magnetic resonance imaging features in prostate cancer before radiotherapy

Physics and imaging in radiation oncology, 2021-01, Vol.17, p.117-123

2021

Volltextzugriff (PDF)

Improved PET/MRI attenuation correction in the pelvic region using a statistical decomposition method on T2-weighted images

EJNMMI physics, 2020-11, Vol.7 (1), Article 68

2020

Volltextzugriff (PDF)

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

The Lancet (British edition), 2019-08, Vol.394 (10196), p.385-395

2019

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(91)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(46)
Science & Technology
(46)
Prostate Cancer
(32)
Medicin Och Hälsovetenskap
(31)
Oncology
(29)
Humans
(26)
Male
(26)
Cancer And Oncology
(14)
Cancer Och Onkologi
(14)
Urology & Nephrology
(14)
Middle Aged
(13)
Patients
(13)
Aged
(12)
Radiotherapy
(11)
Metastasis
(10)
Urologi Och Njurmedicin
(10)
Urology And Nephrology
(10)
Prostatic Neoplasms - Drug Therapy
(9)
Radiology, Nuclear Medicine & Medical Imaging
(9)
Cancer Therapies
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Socioeconomic inequality in prostate cancer diagnostics, primary treatment, rehabilitation, and mortality in Sweden

Risk of severe late toxicity after radiotherapy following radical prostatectomy – a nationwide study

Re‐treatment with radium‐223: 2‐year follow‐up from an international, open‐label, phase 1/2 study in patients with castration‐resistant prostate cancer and bone metastases

Hyaluronic acid spacer in prostate cancer radiotherapy: dosimetric effects, spacer stability and long-term toxicity and PRO in a phase II study

Accuracy of gross tumour volume delineation with [68Ga]-PSMA-PET compared to histopathology for high-risk prostate cancer

Deep learning‐based classification and structure name standardization for organ at risk and target delineations in prostate cancer radiotherapy

The Swedish national guidelines on prostate cancer, part 1: early detection, diagnostics, staging, patient support and primary management of non-metastatic disease

Epithelial and Stromal Characteristics of Primary Tumors Predict the Bone Metastatic Subtype of Prostate Cancer and Patient Survival after Androgen-Deprivation Therapy

Registration of histopathology to magnetic resonance imaging of prostate cancer

Clinical and biological relevance of the transcriptomic‐based prostate cancer metastasis subtypes MetA‐C

Characteristics of Patients in SPCG-15—A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate Cancer

The grade of individual prostate cancer lesions predicted by magnetic resonance imaging and positron emission tomography

Patient-induced susceptibility effects simulation in magnetic resonance imaging

Platelets harbor prostate cancer biomarkers and the ability to predict therapeutic response to abiraterone in castration resistant patients

Estrogen Receptor β Polymorphism Is Associated with Prostate Cancer Risk

The Swedish national guidelines on prostate cancer, part 2: recurrent, metastatic and castration resistant disease

Quantifying the Effect of 3T Magnetic Resonance Imaging Residual System Distortions and Patient-Induced Susceptibility Distortions on Radiation Therapy Treatment Planning for Prostate Cancer

Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial

U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden

11C-Acetate-PET/CT Compared to 99mTc-HDP Bone Scintigraphy in Primary Staging of High-risk Prostate Cancer

High Monocyte Count and Expression of S100A9 and S100A12 in Peripheral Blood Mononuclear Cells Are Associated with Poor Outcome in Patients with Metastatic Prostate Cancer

Histopathology-validated gross tumor volume delineations of intraprostatic lesions using PSMA-positron emission tomography/multiparametric magnetic resonance imaging

Impact of neoadjuvant androgen deprivation therapy on magnetic resonance imaging features in prostate cancer before radiotherapy

Improved PET/MRI attenuation correction in the pelvic region using a statistical decomposition method on T2-weighted images

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

Aktive Filter

Suchergebnisse filtern